Challenged to do more with less in today’s economic climate, many healthcare organizations have turned to consolidation as a way to streamline operations, address pricing pressure from US health reforms, and to better compete and become more efficient healthcare providers. It was a historical year for M&A activity in life science and healthcare with North American companies leading off with 69 percent of the deals announced in 2015. The pharmaceuticals sector leads with increased deal activity year-over-year. Healthcare is the next largest sector trailing slightly behind in deal activity. For hospitals, pharmaceutical companies, medical device makers and other healthcare entities, the trend toward mergers and acquisitions shows no signs of slowing.
Organizations that are contemplating strategic transactions need legal partners who are clearly focused on the bigger picture as well as the details. Husch Blackwell’s healthcare lawyers have the deep experience and knowledge to support your business in any transaction, from the initial stages through closing.
We understand your strategies, goals and objectives and work to define the appropriate scope of due diligence. We identify and resolve critical issues such as deal structure, valuation and financing expectations and structures, pre-merger notification requirements, state attorney general approvals, third-party consent requirements and risk mitigation. We also work closely with our clients’ governing bodies to provide guidance regarding fiduciary duties in strategic transactions. Our diverse team includes not only transactional attorneys but also litigators, intellectual property attorneys and FDA specialists.
Our team delivers solutions on a full range of transaction structures:
Political and community reaction to proposed transactions involving healthcare providers, especially hospitals, often must be addressed to successfully complete a transaction. Our attorneys can help develop and execute effective communication plans and community-oriented solutions.
When the parties will share control of the enterprise after closing, our team can assist in determining governance and control structures, operating agreements, termination agreements and buyout options. We also can work with you to modify or renegotiate payor contracts, IT agreements and other material third-party arrangements.
The team offers extensive expertise in all areas of corporate law, with particularly well-regarded strength handling high-profile M&A transactions.